Aβ Induces Astrocytic Glutamate Release, Extrasynaptic NMDA Receptor Activation, and Synaptic Loss

Synaptic loss is the cardinal feature linking neuropathology to cognitive decline in Alzheimer's disease (AD). However, the mechanism of synaptic damage remains incompletely understood. Here, using FRET-based glutamate sensor imaging, we show that amyloid-β peptide (Aβ) engages α7 nicotinic acetylcholine receptors to induce release of astrocytic glutamate, which in turn activates extrasynaptic NMDA receptors (eNMDARs) on neurons. In hippocampal autapses, this eNMDAR activity is followed by reduction in evoked and miniature excitatory postsynaptic currents (mEPSCs). Decreased mEPSC frequency may reflect early synaptic injury because of concurrent eNMDAR-mediated NO production, tau phosphorylation, and caspase-3 activation, each of which is implicated in spine loss. In hippocampal slices, oligomeric Aβ induces eNMDAR-mediated synaptic depression. In AD-transgenic mice compared with wild type, whole-cell recordings revealed excessive tonic eNMDAR activity accompanied by eNMDAR-sensitive loss of mEPSCs. Importantly, the improved NMDAR antagonist NitroMemantine, which selectively inhibits extrasynaptic over physiological synaptic NMDAR activity, protects synapses from Aβ-induced damage both in vitro and in vivo.

Citing Articles

S-Nitrosylation of CRTC1 in Alzheimer's disease impairs CREB-dependent gene expression induced by neuronal activity.

Zhang X, Vlkolinsky R, Wu C, Dolatabadi N, Scott H, Prikhodko O Proc Natl Acad Sci U S A. 2025; 122(9):e2418179122.

PMID: 40014571 PMC: 11892585. DOI: 10.1073/pnas.2418179122.

Natural Anti-NMDAR1 Autoantibodies Associate with Slowed Decline of Cognitive Functions in Alzheimer's Diseases.

Zhou X medRxiv. 2025; .

PMID: 39974092 PMC: 11838983. DOI: 10.1101/2025.01.16.25320688.

Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease.

Carles A, Freyssin A, Guehairia S, Reguero T, Vignes M, Hirbec H Alzheimers Res Ther. 2025; 17(1):7.

PMID: 39762936 PMC: 11702188. DOI: 10.1186/s13195-024-01648-9.

Increased GABBR2 Expression on Cell Membranes Causes Increased Ca2 + Inward Flow, Associated with Cognitive Impairment in Early Alzheimer's Disease.

Weng Y, Xie G Biochem Genet. 2024; .

PMID: 39724481 DOI: 10.1007/s10528-024-11004-z.

A-mediated synaptic glutamate dynamics and calcium dynamics in astrocytes associated with Alzheimer's disease.

Li Y, Yang X Cogn Neurodyn. 2024; 18(6):3401-3426.

PMID: 39712135 PMC: 11655814. DOI: 10.1007/s11571-024-10064-6.

References

Hardingham G, Fukunaga Y, Bading H . Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002; 5(5):405-14. DOI: 10.1038/nn835. View

Maskell P, Speder P, Newberry N, Bermudez I . Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors. Br J Pharmacol. 2003; 140(7):1313-9. PMC: 1574144. DOI: 10.1038/sj.bjp.0705559. View

Renner M, Lacor P, Velasco P, Xu J, Contractor A, Klein W . Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron. 2010; 66(5):739-54. PMC: 3111138. DOI: 10.1016/j.neuron.2010.04.029. View

Abramov E, Dolev I, Fogel H, Ciccotosto G, Ruff E, Slutsky I . Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci. 2009; 12(12):1567-76. DOI: 10.1038/nn.2433. View

Kollen M, Dutar P, Jouvenceau A . The magnitude of hippocampal long term depression depends on the synaptic location of activated NR2-containing N-methyl-D-aspartate receptors. Neuroscience. 2008; 154(4):1308-17. DOI: 10.1016/j.neuroscience.2008.04.045. View

Song M, Rauw G, Baker G, Kar S . Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur J Neurosci. 2008; 28(10):1989-2002. DOI: 10.1111/j.1460-9568.2008.06498.x. View

Sydow A, Van der Jeugd A, Zheng F, Ahmed T, Balschun D, Petrova O . Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J Neurosci. 2011; 31(7):2511-25. PMC: 6623704. DOI: 10.1523/JNEUROSCI.5245-10.2011. View

Jo J, Whitcomb D, Olsen K, Kerrigan T, Lo S, Bru-Mercier G . Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β. Nat Neurosci. 2011; 14(5):545-7. DOI: 10.1038/nn.2785. View

Parpura V, Basarsky T, Liu F, Jeftinija K, Jeftinija S, Haydon P . Glutamate-mediated astrocyte-neuron signalling. Nature. 1994; 369(6483):744-7. DOI: 10.1038/369744a0. View

10.

Dawson V, Dawson T, London E, Bredt D, Snyder S . Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A. 1991; 88(14):6368-71. PMC: 52084. DOI: 10.1073/pnas.88.14.6368. View

11.

Tampellini D, Capetillo-Zarate E, Dumont M, Huang Z, Yu F, Lin M . Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J Neurosci. 2010; 30(43):14299-304. PMC: 2972675. DOI: 10.1523/JNEUROSCI.3383-10.2010. View

12.

Hoover B, Reed M, Su J, Penrod R, Kotilinek L, Grant M . Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010; 68(6):1067-81. PMC: 3026458. DOI: 10.1016/j.neuron.2010.11.030. View

13.

Hardingham G, Bading H . Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci. 2010; 11(10):682-96. PMC: 2948541. DOI: 10.1038/nrn2911. View

14.

Papouin T, Ladepeche L, Ruel J, Sacchi S, Labasque M, Hanini M . Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell. 2012; 150(3):633-46. DOI: 10.1016/j.cell.2012.06.029. View

15.

Roberson E, Halabisky B, Yoo J, Yao J, Chin J, Yan F . Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci. 2011; 31(2):700-11. PMC: 3325794. DOI: 10.1523/JNEUROSCI.4152-10.2011. View

16.

Wang H, Lee D, Dandrea M, Peterson P, Shank R, Reitz A . beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem. 2000; 275(8):5626-32. DOI: 10.1074/jbc.275.8.5626. View

17.

Lee H, Kameyama K, Huganir R, Bear M . NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus. Neuron. 1998; 21(5):1151-62. DOI: 10.1016/s0896-6273(00)80632-7. View

18.

Wei W, Nguyen L, Kessels H, Hagiwara H, Sisodia S, Malinow R . Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci. 2009; 13(2):190-6. PMC: 3310198. DOI: 10.1038/nn.2476. View

19.

Wang Y, Eu J, Washburn M, Gong T, Chen H, James W . The pharmacology of aminoadamantane nitrates. Curr Alzheimer Res. 2006; 3(3):201-4. DOI: 10.2174/156720506777632808. View

20.

Tomiyama T, Matsuyama S, Iso H, Umeda T, Takuma H, Ohnishi K . A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J Neurosci. 2010; 30(14):4845-56. PMC: 6632783. DOI: 10.1523/JNEUROSCI.5825-09.2010. View